• UCLA Health
  • myUCLAhealth
  • School of Medicine
Institute of Urologic Oncology

UCLA Institute of Urologic Oncology

Institute of Urologic Oncology
  • About Us
    • Director's Welcome
    • Board of Directors
    • IUO in the News
    • Why Choose the UCLA IUO
    • Support the IUO
    • Contact Us
    • The Wasserman Building
    • Maps and Directions
    • IUO Membership Information
    • Administrative & Research Staff
    • Positions Available
  • Clinical Programs
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
    • Testicular Cancer
    • Integrated Cancer Program
    • Cancer Genetic Risk Assessment Program
    • Second Opinion for Cancer
  • Research Programs
    • Clinical Trials
    • Faculty Labs
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
    • LuPSMA Risk Calculator
    • PSMA Risk Calculator
    • SPORE In Prostate Cancer
    • Webinars / Videos
  • Clinical Trials
    • What Is a Clinical Trial?
    • Who Should Consider Clinical Trials & Why
    • Bladder Cancer Clinical Trials
    • Kidney Cancer Clinical Trials
    • Prostate Cancer Clinical Trials
    • Testicular Cancer Clinical Trials
    • Clinical Research Team
    • IUO Membership Study Information
  • For Patients
    • Contact Us
    • Clinical Updates
    • Maps and Directions
    • myUCLAhealth
    • Webinars / Videos
  • Fellowship
    • Current Fellows
    • Former Fellows
    • Fellow Testimonials
    • UCLA Health Aerial Tour
    • Webinars/Videos
  • For Healthcare Professionals
    • How to Refer a Patient
    • Lectures & Conferences
    • CTSI Distinguished Speaker Seminar Series
    • DGSOM Research Seminars
    • DGSOM Events
    • JCCC Seminars
    • Researcher Resources
    • SPORE Lectures
  • Expert Team
    • Board of Directors
    • Medical Oncology
    • Nuclear Medicine
    • Pathology
    • Radiation Oncology
    • Radiology
    • Urologic Oncology
    • Research Faculty
    • Emeritus Faculty
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

UCLA Institute of Urologic Oncology

Research Programs

Research Programs

Research Programs

  • Clinical Trials
  • Faculty Labs
    • Dr. Corey Arnold Lab
      • Meet Our Team
      • Publications
    • Dr. Paul Boutros Lab
      • Research Areas
      • Meet Our Team
      • Publications
    • Dr. Jeremie Calais Lab
      • Research Areas
      • Meet Our Team
      • Publications
      • Videos
    • Dr. Karim Chamie Lab
      • Meet Our Team
      • Publications
    • Dr. Andrew Goldstein Lab
      • Research Areas
      • Meet Our Team
      • Publications
    • Dr. William Hsu Lab
      • Meet Our Team
      • Publications
    • Dr. Amar Kishan Research
      • Meet Our Team
      • Publications
    • Drs. Lueckerath/Mona Lab
      • Meet Our Team
      • Publications
    • Dr. Leonard S Marks Lab
      • Meet Our Team
      • Publications
    • Dr. Robert Reiter Lab
      • Meet Our Team
      • Publications
    • Dr. Lily Wu Lab
      • Meet Our Team
      • Publications
  • Bladder Cancer
  • Kidney Cancer
    • Unique Tumor Repository Launched
  • Prostate Cancer
  • LuPSMA Risk Calculator
  • PSMA Risk Calculator
  • SPORE In Prostate Cancer
  • Webinars / Videos
  • Clinical Trials
  • Faculty Labs
  • Bladder Cancer
  • Kidney Cancer
  • Prostate Cancer
  • LuPSMA Risk Calculator
  • PSMA Risk Calculator
  • SPORE In Prostate Cancer
  • Webinars / Videos
  • Dr. Corey Arnold Lab
  • Dr. Paul Boutros Lab
  • Dr. Jeremie Calais Lab
  • Dr. Karim Chamie Lab
  • Dr. Andrew Goldstein Lab
  • Dr. William Hsu Lab
  • Dr. Amar Kishan Research
  • Drs. Lueckerath/Mona Lab
  • Dr. Leonard S Marks Lab
  • Dr. Robert Reiter Lab
  • Dr. Lily Wu Lab
  • Research Areas
  • Meet Our Team
  • Publications
  1. Home
  2. Institute of Urologic Oncology
  3. Research Programs
  4. Faculty Labs
  5. Dr. Andrew Goldstein Lab

Dr. Andrew Goldstein Lab

Share this

The research in the Goldstein laboratory is focused on the intersection between cancer biology, aging and metabolism with an emphasis on defining mechanisms that regulate prostate tumorigenesis. Prostate cancer is a leading cause of cancer and cancer-related deaths worldwide. A better understanding of prostate cancer initiation, progression and treatment-resistance is critical for developing new therapies to extend life and reduce deaths from prostate cancer. Dr. Goldstein and colleagues have worked to define progenitor cells in the mouse and human prostate and demonstrate that these progenitor cells are susceptible to oncogenic transformation (Science) and can initiate prostate cancer. Aging and chronic inflammation are risk factors for prostate cancer, but the mechanisms by which they increase disease risk has been poorly understood. The Goldstein lab has characterized inflammatory cells in the mouse and human prostate using mass cytometry (AJCEU), and found that luminal progenitor cells are expanded in regions of chronic inflammation (Cell Reports) and in the aging prostate (Cell Reports), suggesting that age and inflammation are associated with an increased population of progenitor cells at risk for transformation. As epithelial cells undergo aging and malignant transformation, they exhibit metabolic reprogramming to support changes in energy demands and a changing microenvironment. The Goldstein lab is investigating how these metabolic changes enable prostate cancer initiation and progression (Cancer & Metabolism).

Lab Team

Research Areas >  | Publications > | Meet Our Team >


Paul

Andrew Goldstein, PhD

Andrew Goldstein, Ph.D., is an Assistant Professor in the departments of Molecular, Cell & Developmental Biology and Urology, and a member of the Broad Stem Cell Research Center and Jonsson Comprehensive Cancer Center at UCLA. Dr. Goldstein attended Dartmouth College in Hanover, New Hampshire where he majored in Biochemistry and Molecular Biology and was a two-time NCAA Division 1 All-American lacrosse player. Dr. Goldstein moved to UCLA where he completed his Ph.D. in the laboratory of Dr. Owen Witte, isolating epithelial progenitor cells from mouse and human prostate tissue and demonstrating the capacity of progenitor cells to respond to oncogenic transformation. This work included the first demonstration of a cell of origin for human prostate cancer reported in Science Magazine. In 2011, Dr. Goldstein became the Inaugural fellow of the Broad Stem Cell Research Center and received a Prostate Cancer Foundation Young Investigator Award and a Department of Defense Prostate Cancer Research Program Idea Development Award to elucidate the cellular and molecular mechanisms promoting epithelial cancer initiation, progression and resistance to treatment. Dr. Goldstein was awarded the 2018 Giants of Science Hope Award from the American Cancer Society and a 2019 Young Investigator Award from the Society for Basic Urologic Research.


Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-310-825-2631
  • Maps & Directions
  • Contact Us
  • Your Feedback
  • Report Misconduct
  • Get Social
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest